Accelerate Diagnostics, Inc.
3950 South Country Club Road, Suite 470
Tucson, Arizona 85714
February 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | Accelerate Diagnostics, Inc. Registration Statement on Form S-3 File No. 333-262494 Request for Acceleration of Effectiveness |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on Friday, February 11, 2022, or as soon thereafter as practicable.
The Registrant hereby authorizes Daniel M. Mahoney and Joshua Schneiderman, of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.
[SIGNATURE PAGE FOLLOWS]
| Very truly yours, | ||
| ACCELERATE DIAGNOSTICS, INC. | ||
| By: | /s/ Steve Reichling | |
| Name: | Steve Reichling | |
| Title: | Chief Financial Officer | |
[SIGNATURE PAGE TO REQUEST FOR ACCELERATION]
